haloperidol has been researched along with lassbio-579 in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Antonio, CB; Barreiro, EJ; Fraga, CA; Grazziottin, LR; Menegatti, R; Neves, G; Noël, F; Rates, SM; Vieira, RO | 1 |
Alves, FR; Antonio, CB; Barreiro, EJ; Figueiredo, CD; Fraga, CA; Herzfeldt, V; Moura, BC; Noël, F; Pompeu, TE; Rates, SM | 1 |
Barreiro, EJ; Betti, AH; Conrado, DJ; Fraga, CA; Kliemann, M; Neves, G; Rates, SM; Tasso, L | 1 |
Barreiro, EJ; Bosier, B; Fraga, CA; Hermans, E; Menegatti, R; Monteiro do Monte, F; Noël, F; Pompeu, TE | 1 |
Antonio, CB; Barreiro, EJ; Betti, AH; Fraga, CA; Herzfeldt, V; Rates, SM | 1 |
5 other study(ies) available for haloperidol and lassbio-579
Article | Year |
---|---|
Searching for multi-target antipsychotics: Discovery of orally active heterocyclic N-phenylpiperazine ligands of D2-like and 5-HT1A receptors.
Topics: Administration, Oral; Animals; Antipsychotic Agents; Cell Line; Humans; Ligands; Male; Mice; Piperazines; Pyrazoles; Rats; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D2; Schizophrenia | 2010 |
Synthesis and pharmacological evaluation of new N-phenylpiperazine derivatives designed as homologues of the antipsychotic lead compound LASSBio-579.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Chemistry Techniques, Synthetic; Dose-Response Relationship, Drug; Drug Design; Locomotion; Male; Mice; Piperazines; Receptor, Serotonin, 5-HT2A; Schizophrenia | 2013 |
Serotonergic neurotransmission mediates hypothermia induced by the N-phenylpiperazine antipsychotic prototypes LASSBio-579 and LASSBio-581.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Body Temperature; Haloperidol; Hypothermia; Injections, Intraperitoneal; Male; Mice; Piperazines; Pyridines; Serotonin; Serotonin Antagonists; Synaptic Transmission | 2008 |
Partial agonism and fast dissociation of LASSBio-579 at dopamine D2 receptor.
Topics: Antipsychotic Agents; Aripiprazole; Cell Membrane; Clozapine; Corpus Striatum; Dopamine Agonists; Guanosine 5'-O-(3-Thiotriphosphate); Haloperidol; HEK293 Cells; Humans; Kinetics; Piperazines; Radioligand Assay; Receptors, Dopamine D2; Transfection | 2015 |
LASSBio-579, a prototype antipsychotic drug, and clozapine are effective in novel object recognition task, a recognition memory model.
Topics: Animals; Antipsychotic Agents; Clozapine; Disease Models, Animal; Haloperidol; Ketamine; Male; Memory, Long-Term; Memory, Short-Term; Mice; Piperazines; Recognition, Psychology; Schizophrenia; Time Factors | 2016 |